Nanopore long-read sequencing for the critically ill facilitates ultrarapid diagnostics and urgent clinical decision making
Authors:
- Daphne J. SmitsDSDaphne J. Smits
- Federico FerraroFFFederico Ferraro
- Mark DrostMDMark Drost
- Herma C. van der LindeHLHerma C. van der Linde
- Bianca M. de GraafBGBianca M. de Graaf
- Yolande van BeverYBYolande van Bever
- Livija BardinaLBLivija Bardina
- Hennie T. BrüggenwirthHBHennie T. Brüggenwirth
- Christophe DebuyCDChristophe Debuy
- Laura Donker KaatLKLaura Donker Kaat
Open Access
- 20 October 2025
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 34 (1) , 108-118
Abstract
Critically ill pediatric patients often have genetic disorders requiring a rapid diagnosis to guide urgent care decisions. Standard genetic testing typically takes weeks and requires multiple tests. Nanopore long-read genome sequencing (LR-GS) delivers genome-wide results within days as a one-test-fits-all solution. As one of the first centers in Europe, we implement ultrarapid LR-GS for critically ill patients. We enrolled 26 critically ill patients (median age 2 months) suspected of having a genetic disorder at the intensive care unit to perform (ultra)rapid nanopore LR-GS alongside standard genomic care. We compared diagnostic yield, turnaround time (TAT), and evaluated the impact on clinical decision making. In 11/26 cases a genetic diagnosis was made with (ultra)rapid LR-GS. From sample receipt to result, the average TAT was 5.3 days (range 2.0–10.8) for LR-GS and 18.4 days (range 6.1–29.1) for standard genomic care. DNA methylation analysis from LR-GS expedited the diagnosis in 3/26 cases. In 7/11 solved cases ultrarapid LR-GS led to immediate adjustments in patient care, e.g., medication switch or termination of treatment. Our findings underscore the clinical impact of ultrarapid LR-GS, including added value of methylation analysis, for critically ill patients and highlight existing challenges, paving the way to ultrarapid LR-GS integration into standard diagnostics.Keywords
This publication has 35 references indexed in Scilit:
- National Rapid Genome Sequencing in Neonatal Intensive CareJAMA Network Open, 2024
- DNA methylation signatures for chromatinopathies: current challenges and future applicationsHuman Genetics, 2023
- Project Baby Bear: Rapid precision care incorporating rWGS in 5 California children’s hospitals demonstrates improved clinical outcomes and reduced costs of careThe American Journal of Human Genetics, 2021
- EpigenCentral: Portal for DNA methylation data analysis and classification in rare diseasesHuman Mutation, 2020
- Feasibility of Ultra-Rapid Exome Sequencing in Critically Ill Infants and Children With Suspected Monogenic Conditions in the Australian Public Health Care SystemJAMA, 2020
- Megabase Length Hypermutation Accompanies Human Structural Variation at 17p11.2Cell, 2019
- Predicting Splicing from Primary Sequence with Deep LearningCell, 2019
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsThe American Journal of Human Genetics, 2016
- Next-generation diagnostics and disease-gene discovery with the ExomiserNature Protocols, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015